Holen Sie sich die Stockscreener-App
7.99
11.13%
0.80
Schlusskurs vom Vortag:
$7.19
Offen:
$7.14
24-Stunden-Volumen:
1.23M
Relative Volume:
12.12
Marktkapitalisierung:
$83.90M
Einnahmen:
$1.93M
Nettoeinkommen (Verlust:
$-7.96M
KGV:
-0.00226
EPS:
-3530.8178
Netto-Cashflow:
$-36.78M
1W Leistung:
+15.80%
1M Leistung:
+4.31%
6M Leistung:
-2.56%
1J Leistung:
+42.17%
1-Tages-Spanne:
$7.07
$8.40
1-Wochen-Bereich:
$6.4758
$8.90
52-Wochen-Spanne:
$4.35
$34.46
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Firmenname
Avalo Therapeutics Inc
Sektor
Branche
Telefon
410-522-8707
Adresse
540 GAITHER ROAD, ROCKVILLE
Vergleichen Sie AVTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
7.99 | 83.90M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.34 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.16 | 78.51B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
580.43 | 35.27B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
238.74 | 30.91B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
245.71 | 26.37B | 3.32B | -860.46M | -1.04B | -8.32 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-28 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-21 | Eingeleitet | Wedbush | Outperform |
| 2024-12-19 | Eingeleitet | BTIG Research | Buy |
| 2024-10-24 | Eingeleitet | H.C. Wainwright | Neutral |
| 2024-04-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-09-24 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Avalo Therapeutics Inc Aktie (AVTX) Neueste Nachrichten
PSTV Rallies, TOVX Gears Up For VIRAGE Trial Data, Will AVTX's LOTUS Bloom? - RTTNews
(AVTX) Investment Analysis - Stock Traders Daily
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Update - Defense World
Avalo Therapeutics (NASDAQ:AVTX) Coverage Initiated at Piper Sandler - Defense World
Avalo Therapeutics (NASDAQ:AVTX) Coverage Initiated by Analysts at Piper Sandler - MarketBeat
Piper Sandler Initiates Coverage of Avalo Therapeutics (AVTX) with Overweight Recommendation - Nasdaq
This CoStar Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga India
Piper Sandler Initiates Avalo Therapeutics at Overweight With $48 Price Target -February 28, 2025 at 07:54 am EST - Marketscreener.com
Piper Sandler sets $48 target on Avalo Therapeutics stock - Investing.com
Avalo Therapeutics (NASDAQ:AVTX) Upgraded by Wedbush to "Strong-Buy" Rating - MarketBeat
Avalo Therapeutics (NASDAQ:AVTX) Now Covered by Analysts at Wedbush - MarketBeat
Avalo Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Avalo Therapeutics (NASDAQ:AVTX) Trading Up 3.1%Time to Buy? - MarketBeat
Avalo Therapeutics initiated with an Outperform at Wedbush - MSN
Avalo Therapeutics (NASDAQ:AVTX) Coverage Initiated at Wedbush - Defense World
Avalo Therapeutics (NASDAQ:AVTX) Upgraded at Wedbush - Defense World
Avalo climbs as Wedbush issues bullish view on lead asset - MSN
(AVTX) Trading Advice - Stock Traders Daily
Avalo stock climbs on Wedbush bullish view (AVTX:NASDAQ) - Seeking Alpha
Wedbush Initiates Avalo Therapeutics With Outperform Rating, $18 Price Target -February 21, 2025 at 07:51 am EST - Marketscreener.com
(AVTX) Technical Data - Stock Traders Daily
Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference - GlobeNewswire
Avalo Therapeutics to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference - The Manila Times
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Up 176.2% in January - MarketBeat
(AVTX) Investment Report - Stock Traders Daily
When (AVTX) Moves Investors should Listen - Stock Traders Daily
AVTX (Avalo Therapeutics) Cash From Discontinued Investing Activities : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Drops By 11.8% - MarketBeat
Avalo Therapeutics (NASDAQ:AVTX) Trading Up 6.5%Still a Buy? - MarketBeat
Avalo Therapeutics (NASDAQ:AVTX) Stock Price Up 6.5% – Still a Buy? - Defense World
(AVTX) Trading Signals - Stock Traders Daily
Avalo Therapeutics appoints first chief strategy officer - Pennsylvania Business Report
Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer - citybiz
Avalo Therapeutics Names Biogen Veteran Jennifer Riley as Chief Strategy Officer to Lead $10B Market Push - StockTitan
(AVTX) Proactive Strategies - Stock Traders Daily
Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Increases By 340.4% - MarketBeat
BTIG Research Begins Coverage on Avalo Therapeutics (NASDAQ:AVTX) - Defense World
Avalo Therapeutics initiated with a Buy at BTIG - Yahoo Finance
BTIG optimistic on Avalo Therapeutics stock with potential for transformative Phase 2b trial results - Investing.com Canada
(AVTX) Trading Report - Stock Traders Daily
LUCID CAPITAL MARKETS Initiates Coverage of Avalo Therapeutics (AVTX) with Buy Recommendation - MSN
Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Drops By 46.9% - MarketBeat
Avalo Therapeutics (AVTX) Is a Potential Hidden Gem with Significant Risk - TipRanks
Trading (AVTX) With Integrated Risk Controls - Stock Traders Daily
Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.14%
2.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):